DME (psychedelic)

DME (psychedelic)
Names
	IUPAC name 2-Amino-1-(3,4-dimethoxy-phenyl)-ethanol
	Other names 3,4-Dimethoxy-beta-hydroxyphenethylamine; 3,4-Dimethoxy-1-ethyl-(beta-hydroxy)amine
Identifiers
CAS Number	6924-15-8 ;
3D model (Jmol)	Interactive image; Interactive image;
ChemSpider	3088871 ;
PubChem CID	3863978;
	InChI InChI=1S/C10H15NO3/c1-13-9-4-3-7(8(12)6-11)5-10(9)14-2/h3-5,8,12H,6,11H2,1-2H3 Key: WIUFFBGZBFVVDL-UHFFFAOYSA-N ; InChI=1/C10H15NO3/c1-13-9-4-3-7(8(12)6-11)5-10(9)14-2/h3-5,8,12H,6,11H2,1-2H3 Key: WIUFFBGZBFVVDL-UHFFFAOYAL ;
	SMILES COc1cc(ccc1OC)C(O)CN ; O(c1ccc(cc1OC)C(O)CN)C ;
Properties
Chemical formula	C10H15NO3
Molar mass	197.23 g/mol
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
	verify (what is ?)
	Infobox references

DME, or 3,4-dimethoxy-beta-hydroxy phenethylamine, is a lesser-known psychedelic drug. It is the beta-hydroxy analog of DMA. DME was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 115 mg, and the duration unknown. DME produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of DME.

External links[edit]

This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it.